Pseudomyxoma peritonei laboratory findings: Difference between revisions
Mahshid |
Nima Nasiri (talk | contribs) |
||
| Line 11: | Line 11: | ||
*Carbohydrate antigen 125 ([[CA125]]) | *Carbohydrate antigen 125 ([[CA125]]) | ||
These tumor markers are also used as a baseline value for postoperative follow-up. Moreover, they have been reported as predictors of the completeness of cytoreductive surgery, a significant prognostic factor for pseudomyxoma peritonei. | These tumor markers are also used as a baseline value for postoperative follow-up. Moreover, they have been reported as predictors of the completeness of cytoreductive surgery, a significant prognostic factor for pseudomyxoma peritonei.<ref name="pmid17510772">{{cite journal |vauthors=Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M |title=Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |journal=Ann. Surg. Oncol. |volume=14 |issue=8 |pages=2300–8 |date=August 2007 |pmid=17510772 |doi=10.1245/s10434-007-9393-9 |url=}}</ref> | ||
== References == | == References == | ||
Revision as of 20:39, 11 January 2019
|
Pseudomyxoma peritonei Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pseudomyxoma peritonei laboratory findings On the Web |
|
American Roentgen Ray Society Images of Pseudomyxoma peritonei laboratory findings |
|
Risk calculators and risk factors for Pseudomyxoma peritonei laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
The laboratory findings associated with pseudomyxoma peritonei are increased levels of tumor markers such as carcinoembryonic antigen (CEA), carbohydrate antigen 19.9 (CA19.9), carbohydrate antigen 125 (CA125).[1]
Laboratory Findings
The laboratory findings associated with pseudomyxoma peritonei are increased levels of tumor markers such as:[1]
These tumor markers are also used as a baseline value for postoperative follow-up. Moreover, they have been reported as predictors of the completeness of cytoreductive surgery, a significant prognostic factor for pseudomyxoma peritonei.[2]
References
- ↑ 1.0 1.1 Amini, Afshin; Masoumi-Moghaddam, Samar; Ehteda, Anahid; Morris, David (2014). "Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects". Orphanet Journal of Rare Diseases. 9 (1): 71. doi:10.1186/1750-1172-9-71. ISSN 1750-1172.
- ↑ Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M (August 2007). "Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy". Ann. Surg. Oncol. 14 (8): 2300–8. doi:10.1245/s10434-007-9393-9. PMID 17510772.